Drug Type Synthetic peptide |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myelofibrosis | Phase 1 | DK | 20 Jun 2018 | |
Thrombocythemia, Essential | Phase 1 | DK | 20 Jun 2018 | |
Myeloproliferative Disorders | Phase 1 | - | - |